Skip to main contentPancreatic head cancer treatment in Ahmedabad and Gandhinagar · Dr Harsh Shah · Pancreas Cancer Surgeon · Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
A shadow in the head of the pancreas on a scan does not, by itself, mean an operation — and it does not always mean cancer. Four questions are answered in a fixed order before anyone talks about treatment: is this a pancreatic cancer or one of the conditions that imitate it; if it is cancer, which of four anatomical groups it falls into on the right scan; is the patient fit for the treatment that group needs; and what does that group need first — an operation, chemotherapy before any operation, or treatment aimed at comfort and control. The Whipple operation is one rung on that ladder, not the whole ladder, and Dr Harsh Shah treats every rung of it at Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad.
Dr. Jivraj Mehta Hospital
Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Pancreas Cancer Surgeon
· Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Qualified twice over in surgical gastroenterology and trained in high-volume units, Dr Harsh Shah looks after the whole range of pancreatic disease — inflammation, cysts and cancer — so a head mass reaches him at the point where it most needs sorting. Google rating 4.94 from 18 reviews at the Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad listing.
The head of the pancreas sits in the curve of the duodenum, around the lower bile duct and on the great veins that drain the bowel. A growth there shows itself by what it presses on: the bile duct, so the eyes turn yellow; the duodenum, so food stops passing; the nerves behind the gland, so pain runs to the back.
The signs that should send an adult for a proper pancreatic scan: jaundice without pain or fever; upper abdominal pain through to the back, easier sitting forward; weight falling with appetite gone; diabetes appearing for the first time after fifty with weight loss; an unexplained clot in a leg vein; and pale, greasy stools. None of these proves cancer. Each is a reason to have the right scan read by someone who will decide what the shadow is and what it touches.
Several different conditions produce a mass in the head of the pancreas, and they are treated in opposite ways. Besides pancreatic ductal adenocarcinoma, a tumour of the ampulla or duodenum, a cancer of the lowest bile duct, a neuroendocrine tumour, a cystic tumour and two forms of inflammation can occupy the same space. The inflammatory mass of chronic pancreatitis and autoimmune pancreatitis are not cancer at all — and autoimmune pancreatitis is treated with steroid tablets, not an operation.
| What the mass turns out to be | How it is recognised | What that means for treatment |
|---|---|---|
| Pancreatic ductal adenocarcinoma | Pancreatic-protocol CT, endoscopic ultrasound with a needle sample where tissue is needed, CA 19-9 | Treated by its anatomical group — the ladder below |
| Ampullary or duodenal tumour | Seen and sampled at endoscopy; the ampulla is viewed directly | A different disease; often the same operation, staged on its own terms |
| Cancer of the lower bile duct | Imaging of the duct, endoscopic ultrasound | Operated in the same way, but staged and treated as a bile-duct cancer |
| Neuroendocrine tumour of the pancreas | Its own appearance on CT, confirmed on tissue | A separate tumour type with its own treatment pathway |
| Cystic tumour of the pancreas | Cyst features on MRI and endoscopic ultrasound | Watched or removed according to its risk features |
| Inflammatory head mass in chronic pancreatitis | Background of long-standing pancreatitis, calcification, duct changes | Cancer is excluded explicitly first |
| Autoimmune pancreatitis | A swollen, sausage-shaped gland and a raised IgG4 level | Steroid tablets; this is the mimic that must not be operated on |
The inflammatory mass is the commonest trap. Chronic pancreatitis and cancer can coexist and look identical, so new jaundice, a new lump or faster weight loss is never simply put down to the known pancreatitis. Where the cancer question genuinely cannot be settled, the cancer operation is the safer choice: removing a benign mass is regrettable, missing a carcinoma is worse.
Each test answers one question. The most important is a pancreatic-protocol CT — thin slices, two contrast phases, images rebuilt in more than one plane — because it alone shows which blood vessels the tumour touches. That finding, not the tumour's size, decides whether surgery is possible, and an ordinary abdominal CT cannot answer it.
| Test | The question it answers | When it can be left out |
|---|---|---|
| Pancreatic-protocol CT | Can this be removed — which vessels are involved, and is there spread to the liver | Never; it is the decision-making scan |
| Endoscopic ultrasound, with a needle sample | Is it cancer or a look-alike; provides tissue | Tissue is required before any chemotherapy, but not before an operation for a clearly removable mass |
| CA 19-9 blood test | A baseline to follow response | Misleading while jaundice is high — repeated after drainage; some people never make this marker at all |
| MRI or MRCP | Clarifies an uncertain CT, a doubtful liver spot, or the anatomy of the ducts | When the CT already answers these |
| Staging laparoscopy | Small deposits on the lining of the abdomen that scans miss | Used selectively — large tumours, a marker out of proportion to the jaundice, or doubtful findings |
| Germline genetic test | Inherited BRCA or PALB2 changes, which alter which drugs work and matter for the family | Offered to every patient with this cancer |
| PET-CT | — | Not part of the routine workup |
Two points change the first fortnight. A negative biopsy does not exclude cancer — a needle that misses proves only that it missed. And a bile-duct stent is not automatic: a well patient who can be operated within about two weeks goes ahead without one, while infection in the bile, unbearable itching, kidney strain, a long delay, or chemotherapy before surgery each call for a covered metal stent. Nutrition is assessed alongside the scans, because a patient losing weight tolerates every treatment worse.
Once the mass is confirmed as cancer, the pancreatic-protocol CT places it in one of four groups, each with a different starting point: resectable starts with the operation; borderline resectable with chemotherapy, a fresh scan, then the operation; locally advanced with chemotherapy and re-assessment, because some become operable; spread disease with chemotherapy chosen by fitness and genes, with symptom care. Every case goes to a tumour board first.
| Group on the scan | What the scan shows | Where treatment starts |
|---|---|---|
| Resectable | No contact with the main arteries; the vein untouched or only slightly touched | Operation first, then chemotherapy afterwards |
| Borderline resectable | Limited contact with an artery, or more extensive contact with a vein that can still be rebuilt | Chemotherapy first, a fresh scan and CA 19-9, then the operation |
| Locally advanced | Wrapped around a main artery, or a vein that cannot be rebuilt | Chemotherapy for some months, then re-staging; radiotherapy considered for local control |
| Metastatic | Spread to the liver, the lining of the abdomen, or distant glands | Chemotherapy matched to fitness and genetic results, with symptom care from the start |
Fitness sets the intensity: a patient up and about all day can receive the stronger combination chemotherapy and a major operation; one who rests for part of the day receives a gentler regimen; one confined to bed is helped with symptom control and early palliative care. An inherited BRCA or PALB2 change points to a platinum-based combination. And after chemotherapy the CT often looks unchanged even when treatment has worked, so a falling CA 19-9 in a well patient can justify exploration.
Surgery is not needed — and would do harm — in four situations: when the mass is a look-alike such as autoimmune pancreatitis; when the cancer has spread; when the patient is not fit enough for a major operation; and when the cancer is locally advanced and has not yet responded to chemotherapy. In these situations the problems the tumour causes are still treated, and treated actively, mostly without an incision.
What that treatment consists of:
“No operation” does not mean “nothing can be done”. It means the treatment that helps most is not a knife.
For a resectable cancer of the head of the pancreas, and for a borderline cancer that has responded to chemotherapy, the operation is a pancreatoduodenectomy — the Whipple operation. It removes the head of the pancreas, the duodenum, the lower bile duct, the gallbladder and the surrounding lymph glands in one piece, then rebuilds three connections so that bile, pancreatic juice and food flow into the bowel again. Keeping or removing the outlet valve of the stomach gives the same cancer result.
What matters to the result: a clear margin, checked by the pathologist on each cut surface; a standard clearance of the glands, because an extended one adds complications without benefit; and removal and rebuilding of the main vein where that is what leaves the margins clear. Removing a main artery is not standard practice. For a tumour spreading along the neck of the gland, the whole pancreas is sometimes removed, which means lifelong insulin and enzyme capsules — a trade-off discussed in full beforehand. The join between the remaining pancreas and the bowel decides how recovery goes, so a drain is left beside it and its fluid is tested on the first day.
The complications are serious, and every family hears them before agreeing: leakage from the pancreatic join; a stomach slow to empty, delaying eating by days or weeks; bleeding after the operation — a small warning bleed from a drain is treated as an emergency even when the patient looks well; bile or lymph leakage; a collection of pus; a return to theatre; and a risk to life. Later, many patients need enzyme capsules with meals, and diabetes can appear or worsen. The operation is sometimes stopped when spread is found that no scan showed, and even after complete removal this cancer often returns, which is why chemotherapy usually follows. Dr Harsh Shah goes through each of these personally before consent, with the figures that apply to your own scan, your own fitness and the operation actually planned — they are not general numbers and are not quoted on a page.
This patient had a Whipple operation for a neuroendocrine tumour of the pancreas — one of the head-of-pancreas tumours in the table above — and the recovery is described in the patient’s own words.
Treatment for a pancreatic head mass is covered by cashless health insurance and by corporate schemes at Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad. What moves an estimate is which rung applies — a stent, chemotherapy and a Whipple operation are very different undertakings — with the room category, the length of stay and any intensive care. A written estimate is prepared for your own policy.
Pre-authorisation is arranged by the hospital’s insurance desk, and Dr Harsh Shah’s office prepares the clinical summary. Bring policy papers, identification, every scan on a disc and your regular medicines in their strips. Blood thinners and diabetes medicines need specific written instructions before admission. Cover for chemotherapy given as day care is checked separately with the insurer.
★★★★★
★★★★★
“Met with Dr. Harsh Shah for the consultation of one of my relative. Dr. Harsh Shah is an exceptional surgical oncologist in Ahmedabad. His expertise in treating complex GI cancers like liver, pancreas, and colon cancers is truly remarkable. He explains everything clearly and gives patients full confidence in their treatment. Highly recommended for anyone looking for a skilled and compassionate cancer specialist. — Nagesh Patidar, Google review”
★★★★★
“We are very thankful to Dr. Harsh Shah for successfully performing the Whipple’s procedure. From the beginning, he explained everything clearly and gave us great confidence throughout the treatment. Today, we are happy to share that we received the discharge and are going home with a positive feeling. Thank you, Dr. Harsh Shah, for your expertise, care, and support. Highly recommended for GI surgery. — Desai Sonal, Google review”
Real Google reviews from Dr Harsh Shah’s two listings, reproduced exactly as written.
No. Most such masses in adults do turn out to be cancer, but an inflammatory mass in chronic pancreatitis, autoimmune pancreatitis, an ampullary or duodenal tumour, a neuroendocrine tumour and a cystic tumour can all sit in the same place. The pancreatic-protocol CT and an endoscopic ultrasound, with a needle sample where needed, separate them — and they are treated very differently.
Not always. Tissue is required before any chemotherapy. For a mass that is clearly removable on the right scan, the operation can go ahead without a biopsy — and a negative biopsy would not have excluded cancer anyway, because a needle can miss.
Only for a reason. If the patient is well and the operation can happen within about two weeks, it goes ahead without one. A stent is placed for infection in the bile, severe itching, kidney strain, a long delay ahead, and for everyone receiving chemotherapy before surgery — then a covered metal stent, because plastic ones block.
It depends on which scan that verdict came from and which group the tumour is in. A routine CT cannot decide it. A borderline cancer is treated with chemotherapy first and then operated, and some locally advanced cancers become operable after chemotherapy. Where the cancer has spread, the treatment is chemotherapy and symptom care — which is real treatment, not an absence of it.
Chemotherapy chosen by fitness and by genetic results; a metal stent for jaundice; relief of a blocked duodenum; a coeliac plexus block for back pain; enzyme capsules with meals for weight loss; and palliative care that begins early, alongside everything else.
Dr Harsh Shah consults at Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad.
Patients travel to Dr Harsh Shah from across Gujarat and from Rajasthan and Madhya Pradesh. Chemotherapy, when it comes first, can often be given closer to home on a plan agreed here, with the scans, the decision points and any operation at Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad.
Been told “there is a mass in the pancreas” on an ordinary CT, and nothing more? The scan images and reports can be sent ahead of the appointment, so the consultation starts with them already read; what happens next is decided at the consultation, after examination. Call +91-63555-64601 · Send the scan ahead on WhatsApp
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.